{"id":553626,"date":"2021-07-20T15:54:01","date_gmt":"2021-07-20T15:54:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=553626"},"modified":"2021-07-20T15:54:01","modified_gmt":"2021-07-20T15:54:01","slug":"varicose-ulcer-market-expected-to-grow-due-to-increased-spending-on-rd-as-well-as-the-introduction-of-novel-therapies","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/varicose-ulcer-market-expected-to-grow-due-to-increased-spending-on-rd-as-well-as-the-introduction-of-novel-therapies_553626.html","title":{"rendered":"Varicose Ulcer Market expected to grow due to increased spending on R&#038;D as well as the introduction of novel therapies"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1626765989.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Varicose Ulcer Market expected to grow due to increased spending on R&amp;D as well as the introduction of novel therapies\" src=\"https:\/\/www.abnewswire.com\/uploads\/1626765989.png\" alt=\"Varicose Ulcer Market expected to grow due to increased spending on R&amp;D as well as the introduction of novel therapies\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Varicose Ulcer Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The dynamics of the Varicose Ulcer market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the disease, incremental healthcare spending across the world, and the expected launch of emerging therapies during the forecast period.<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/d6782c3a71d9afefc2ae48b7e02f64cf.jpg\" alt=\"\" \/><\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>DelveInsight&#8217;s <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/varicose-ulcer-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Varicose Ulcer market report<\/a><\/strong>&nbsp;<span>provides a comprehensive understanding of the Varicose Ulcer, historical and forecasted epidemiology, as well as Varicose Ulcer market trends in the 7MM. In order to discover and analyze the market&#8217;s underlying potential, the research also looks at current Varicose Ulcer treatment practices\/algorithms, market drivers, market barriers, and unmet medical needs.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Key Highlights from the Varicose Ulcer Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>As per DelveInsight Varicose Ulcer epidemiology insights, the prevalent cases were estimated to be <\/span><strong>4,231,024<\/strong><span> in the 7MM in 2020 out of which the highest was observed in the US<\/span><span>.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>The highest Varicose Ulcer diagnosed prevalence was observed in the age group of <\/span><span>above <strong>70 years<\/strong><\/span><span> in the United States in 2020.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Among the EU5 countries, <\/span><strong>Germany<\/strong><span> had the highest Varicose Ulcer diagnosed prevalent population while <\/span><strong>Spain<\/strong><span> had the least number of cases in 2020.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>According to DelveInsight, Varicose Ulcer is more common in women as compared to men.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Rheacell, a Ticeba <\/strong><span><strong>subsidiary,<\/strong> is developing <\/span><span>Allogeneic <strong>ABCB5-positive Stem Cells\/ Allo-APZ2-CVU<\/strong><\/span><span> for the treatment of non-healing Chronic Venous ulcers.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Amnio Technology<\/strong><span> received the FDA approval in October 2020 to proceed with a Phase II clinical trial for their amniotic tissue-based product, <\/span><strong>PalinGen<\/strong><span><strong> Flow,<\/strong> under an IND application.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Other Varicose Ulcer therapies in the pipeline include <\/span><strong>TTAX01 (Tissue Tech), EscharEx<\/strong><span><strong> (MediWound),<\/strong> and others.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Key pharmaceutical players such as <\/span><span><strong>Rheacell, MediWound, PRP Concepts, SerenaGroup, Merakris Therapeutics, Amnio Technology, Tissue Tech, Ilkos Therapeutic,<\/strong>&nbsp;<\/span><span>and others are involved in developing treatments for Varicose Ulcer.<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>For better understanding about the disease request sample @ <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/varicose-ulcer-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">What is Varicose Ulcer?<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>The Varicose Ulcer market report<\/span><span> covers current treatment practices, emerging drugs, Varicose Ulcer market share of individual therapies, and current and forecasted Varicose Ulcer market Size from 2018 to 2030, segmented into seven major markets.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Varicose Ulcer: Overview<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Varicose Ulcer, also known as Venous Ulcer, is a full-thickness skin defect that does not heal on its own and is caused by chronic venous disease. It is a skin defect below the knee that develops as a result of faulty venous valves and lasts for more than six weeks with no propensity to mend after three or more months. As a result, they are also known as leg ulcers, lower limb ulcers, or stasis ulcers.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Varicose Ulcer Epidemiology Segmentation<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Varicose Ulcer Prevalent Cases<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Varicose Ulcer Diagnosed Prevalent Cases<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Varicose Leg Ulcer Diagnosed Prevalent Cases<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Varicose Ulcer Type-Specific Distribution<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Varicose Ulcer Gender-Specific Distribution<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Varicose Ulcer Age-Specific Distribution<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Varicose Ulcer Treatment Landscape<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>The current <\/span><span>Varicose Ulcer <\/span><span>treatment includes <\/span><span>Conservative Management, Mechanical Treatment, Medications and Surgical <\/span><span>options. Treatment must be multidisciplinary and individualized based on the patient&#8217;s and illness&#8217;s characteristics. Compression therapy, which includes compression stockings and bandages, is the standard of care for Varicose Ulcer.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Pentoxifylline, Aspirin,<\/span><span> and <\/span><span>Simvastatin<\/span><span>, as well as other <\/span><span>antibiotics, antiseptics,<\/span><span> and <\/span><span>anti-inflammatory<\/span><span> drugs, are also used for Varicose Ulcer treatment. Various growth factors are also administered to speed up the wound-healing process in ulcers.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Got queries? How to cure varicose ulcer? Find out @<strong>&nbsp;<\/strong><\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/varicose-ulcer-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Varicose Veins Ulcer Treatment<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Varicose Ulcer Market<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>The market size of Varicose Ulcer was estimated to be <\/span><strong>USD 1, 626.4 million<\/strong><span> in 7MM in 2020.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>The United States accounted for the largest Varicose Ulcer market size as compared to EU5 and Japan in 2020.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Among the EU5 countries, Germany had the highest Varicose Ulcer market share while Spain captured the lowest Varicose Ulcer market size in 2020.<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Varicose Ulcer Pipeline Therapies and Key Companies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Allo-APZ2-CVU: Rheacell<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>EscharEx: MediWound<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>TTAX01: Tissue Tech<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Varicose Ulcer Market Drivers<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Opportunity for emerging therapies due to low competition<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Easy access to treatment<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Availability of cost-effective care<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Varicose Ulcer Market Barriers<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Non-adherence to treatment<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>One-size-fit for all approach<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Lack of services\/education in place to monitor patients with a healed venous leg ulcer<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Scope for the Report<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Coverage: <\/strong><span>7MM (the US, EU5 (the UK, Germany, Italy, Spain, and France) and Japan)<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Study Period: <\/strong><span>2018-30<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Varicose Ulcer Key Companies: <\/strong><span>Rheacell, MediWound, PRP Concepts, SerenaGroup, Merakris Therapeutics, Amnio Technology, Tissue Tech, Ilkos Therapeutic, among others.<\/span><span>&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Varicose Ulcer Key Pipeline Therapies: <\/strong><span>Allo-APZ2-CVU, EscharEx, TTAX01<\/span><span>, <\/span><span>and others.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Varicose Ulcer Segmentation: <\/strong><span>By Geography, By <\/span><span>Varicose Ulcer<\/span><span> therapies<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Analysis: <\/strong><span>Comparative and conjoint analysis of Varicose Ulcer emerging therapies<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Tools Used: <\/strong><span>SWOT Analysis<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Case Studies<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>KOL&rsquo;s Views<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Analyst&rsquo;s Views<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Contents<\/strong><\/p>\n<div style=\"text-align: justify;\" dir=\"ltr\" align=\"left\">\n<table>\n<colgroup>\n<col width=\"77\" \/>\n<col width=\"547\" \/><\/colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><span>1.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Key Insights<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>2.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Executive Summary<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>3.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>SWOT Analysis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>4.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Varicose Ulcer Market Overview at a Glance<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>5.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Disease Background and Overview: Varicose Ulcer<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>6.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Recognized Establishments<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>7.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Varicose Ulcer Treatment<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>8.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Compression therapy after invasive treatment of superficial veins of the lower extremities: Clinical practice guidelines of the American Venous Forum, Society for Vascular Surgery, American College of Phlebology, Society for Vascular Medicine, and International Union of Phlebology (2019)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>9.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Evidence\u2010based (S3) guidelines for diagnostics and treatment of Venous Leg Ulcers- European Dermatology Forum (2016)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>10.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Wound healing society &#8211; Guidelines for Venous Ulcers (2015)<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>11.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Varicose Ulcer Epidemiology and Patient Population<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>12.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>7MM Epidemiology of Varicose Ulcer<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>13.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Varicose Ulcer Unmet Needs<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>14.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Varicose Ulcer Emerging Drugs<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>15.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Varicose Ulcer Market Access and Reimbursement<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>16.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Varicose Ulcer: Seven Major Market Analysis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>17.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Case Reports<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>18.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Varicose Ulcer Market Drivers<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>19.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Varicose Ulcer Market Barriers<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>20.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>KOL Reviews<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>21.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Appendix<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>22.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>DelveInsight Capabilities<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>23.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Disclaimer<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>24.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>About DelveInsight<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>For rich insights into Healthcare and Pharmaceutical News, visit <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Pharma, Healthcare, and Biotech Blog Posts<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/chronic-venous-ulceration-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Chronic Venous Ulceration Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Get comprehensive historical and forecast analysis of <\/span><span>Chronic Venous Ulceration<\/span><span> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><span><strong>Array Biopharma, Pfizer, Merck, Bristol-Myers Squibb, Eli Lilly, Taiho Oncology, G1 Therapeutics, AB Science, Eisai, Seagen, Effector Therapeutics,<\/strong>&nbsp;<\/span><span>among others.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance<\/span><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Sandeep Joshi<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=varicose-ulcer-market-expected-to-grow-due-to-increased-spending-on-rd-as-well-as-the-introduction-of-novel-therapies\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=varicose-ulcer-market-expected-to-grow-due-to-increased-spending-on-rd-as-well-as-the-introduction-of-novel-therapies\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Varicose Ulcer Market The dynamics of the Varicose Ulcer market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the disease, incremental healthcare spending across the world, and the expected &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/varicose-ulcer-market-expected-to-grow-due-to-increased-spending-on-rd-as-well-as-the-introduction-of-novel-therapies_553626.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,420,403,404],"tags":[],"class_list":["post-553626","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/553626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=553626"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/553626\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=553626"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=553626"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=553626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}